Oral vadadustat three times per week was noninferior to a long-acting erythropoiesis-stimulating agent for treating anemia in patients with chronic kidney disease on dialysis, according to study data.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.